AbstractFirst-line multiple myeloma treatment has evolved from melphalan–prednisone to quadruplet regimens incorporating proteasome inhibitors, immunomodulatory drugs, anti-CD38 monoclonal antibodies, ...
1Rutgers Cancer Institute, New Brunswick, New Jersey. *Corresponding Author: Sharon L. Manne, Rutgers Cancer Institute, 120 Albany Street, Tower 2, Floor 8, New ...
Authors may opt to publish their research under an open access license in any of the AACR hybrid journals. The hybrid AACR journals include: Blood Cancer Discovery; Cancer Discovery; Cancer ...
Abramson Cancer Center, Department of Medicine, Perelman School of Medicine, ...
Abstract. Lipid metabolism reprogramming modulates the tumor microenvironment (TME) and alters the function of immune cells, including tumor-infiltrating lymphocytes (TIL). Although lipids can enhance ...
Senescence as the Next Frontier in Cancer Research: Navigating the Rising Tide of Geriatric Oncology
Pancreas Center, National Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key Laboratory of Digestive Cancer, ...
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. 2Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts.
1Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, United Kingdom. 2Dermatology Centre, Northern Care Alliance NHS Foundation ...
Cancer Discov (2026) 16 (2): OF1.
Cancer Discov (2026) 16 (2): OF1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results